Aratana Therapeutics, Inc.
(NASDAQ : PETX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.28%159.840.7%$1252.13m
LLYEli Lilly & Co. -2.06%326.081.1%$1083.26m
ABBVAbbVie, Inc. -1.40%138.321.9%$848.46m
PFEPfizer Inc. -2.28%42.110.9%$785.00m
BMYBristol-Myers Squibb Co. -0.73%69.731.0%$746.33m
MRKMerck & Co., Inc. -0.19%87.270.7%$696.30m
AZNAstraZeneca Plc 1.04%55.481.0%$390.20m
ALNYAlnylam Pharmaceuticals, Inc. -2.68%196.948.2%$218.79m
GSKGSK Plc 0.48%30.150.3%$209.56m
NVSNovartis AG -0.63%75.570.2%$199.66m
HZNPHorizon Therapeutics Plc -3.93%65.235.4%$181.31m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$178.81m
IDXXIDEXX Laboratories, Inc. -3.15%335.113.9%$178.52m
SRPTSarepta Therapeutics, Inc. -2.72%111.7012.4%$137.88m
AKROAkero Therapeutics, Inc. -1.68%38.600.0%$131.91m

Company Profile

Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.